- Report
- March 2025
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 187 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 187 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- August 2024
- 140 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- May 2024
- 129 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Report
- July 2024
- 150 Pages
Global
From €3565EUR$3,750USD£2,995GBP
- Clinical Trials
- December 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Report
- June 2024
- 200 Pages
Global
From €7558EUR$7,950USD£6,349GBP
- Report
- February 2025
- 182 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 250 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- August 2024
- 145 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- May 2024
- 72 Pages
Global
From €3323EUR$3,495USD£2,791GBP
- Report
- December 2024
- 70 Pages
United States
From €5656EUR$5,950USD£4,752GBP
- Report
- May 2024
- 136 Pages
Global
From €6178EUR$6,499USD£5,190GBP
- Clinical Trials
- June 2024
- 80 Pages
Global
From €1901EUR$2,000USD£1,597GBP
- Clinical Trials
- April 2024
- 50 Pages
Global
From €1426EUR$1,500USD£1,198GBP
- Report
- May 2024
- 200 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- November 2024
- 110 Pages
United States
From €5656EUR$5,950USD£4,752GBP

The Alopecia Drug market is a subset of the Immune Disorders Drugs market, which focuses on treatments for autoimmune diseases. Alopecia is an autoimmune disorder that causes hair loss, and drugs used to treat it are designed to reduce inflammation and suppress the immune system. These drugs are typically administered orally or topically, and may include corticosteroids, immunosuppressants, and biologics.
The Alopecia Drug market is highly competitive, with many companies developing treatments for the disorder. Some of the major players in the market include Pfizer, Novartis, Merck, Johnson & Johnson, and GlaxoSmithKline. Other companies, such as Sun Pharmaceuticals, Cipla, and Dr. Reddy's Laboratories, are also active in the market. Show Less Read more